We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-0.97%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$3.62B
AUM Growth
+$104M
(+3%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
4.33%
Top 10 Holdings %
Top 10 Hldgs %
18.9%
Holding
1,521
New
107
Increased
774
Reduced
496
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$16.7M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$13.5M |
| 3 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$10M |
| 4 |
Vanguard Total International Stock ETF
VXUS
|
+$9.41M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$8.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.1M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$13.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$13.1M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$9.94M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$7.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.26% |
| 2 | Financials | 5.23% |
| 3 | Healthcare | 4.75% |
| 4 | Energy | 4.61% |
| 5 | Industrials | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.39B
| $479K | 0.01% |
15,117
-833
| -5% | -$27.3K |
|
|
CSII
827
DELISTED
Cardiovascular Systems, Inc.
CSII
| $478K | 0.01% |
18,078
-2,719
| -13% | -$87.8K |
|
828
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$243M
| $477K | 0.01% |
22,548
-108
| -0.5% | -$2.23K |
|
829
NXP Semiconductors
NXPI
$59.6B
| $476K | 0.01% |
4,847
+1,066
| +28% | +$109K |
|
|
SRCL
830
DELISTED
Stericycle Inc
SRCL
| $476K | 0.01% |
3,552
+41
| +1% | +$5.62K |
|
831
Dollar Tree
DLTR
$24.6B
| $475K | 0.01% |
6,019
-5,887
| -49% | -$465K |
|
832
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.55B
| $475K | 0.01% |
12,696
+2,643
| +26% | +$104K |
|
833
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$919M
| $474K | 0.01% |
37,800
-2,323
| -6% | -$29.9K |
|
|
CA
834
DELISTED
CA, Inc.
CA
| $474K | 0.01% |
16,167
+9,824
| +155% | +$305K |
|
835
Fulton Financial
FULT
$4.65B
| $473K | 0.01% |
36,219
-417
| -1% | -$5.29K |
|
|
OKS
836
DELISTED
Oneok Partners LP
OKS
| $473K | 0.01% |
13,907
+3,743
| +37% | +$148K |
|
837
Lear
LEA
$8.12B
| $472K | 0.01% |
4,201
-523
| -11% | -$60.1K |
|
838
Regions Financial
RF
$26.9B
| $472K | 0.01% |
45,545
-9,387
| -17% | -$94.6K |
|
839
Robert Half
RHI
$4.31B
| $471K | 0.01% |
8,483
+12
| +0.1% | +$686 |
|
840
America Movil
AMX
$70.3B
| $470K | 0.01% |
22,039
+2,500
| +13% | +$52.7K |
|
|
PDT
841
John Hancock Premium Dividend Fund
PDT
$627M
| $470K | 0.01% |
35,904
+11,864
| +49% | +$163K |
|
842
Sempra
SRE
$55.9B
| $470K | 0.01% |
9,504
-80
| -0.8% | -$4.24K |
|
|
NS
843
DELISTED
NuStar Energy L.P.
NS
| $470K | 0.01% |
7,919
-427
| -5% | -$27K |
|
|
EOI
844
Eaton Vance Enhanced Equity Income Fund
EOI
$830M
| $466K | 0.01% |
35,470
+6,109
| +21% | +$83.6K |
|
845
Cardinal Health
CAH
$55.9B
| $465K | 0.01% |
5,558
+861
| +18% | +$76K |
|
846
GameStop
GME
$8.44B
| $465K | 0.01% |
43,332
+15,296
| +55% | +$157K |
|
|
CMCSK
847
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $465K | 0.01% |
7,756
+41
| +0.5% | +$2.46K |
|
848
Schwab US TIPS ETF
SCHP
$16.2B
| $464K | 0.01% |
17,122
+9,072
| +113% | +$248K |
|
849
Zoetis
ZTS
$31.1B
| $464K | 0.01% |
9,616
+3,945
| +70% | +$188K |
|
|
PDLI
850
DELISTED
PDL BioPharma, Inc.
PDLI
| $464K | 0.01% |
72,185
+48,282
| +202% | +$323K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, Cambridge Investment Research Advisors held 1,521 positions worth $3.62B, up 3% from $3.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cambridge Investment Research Advisors deployed $157M of net new capital in Q2 2015, opening 107 new positions and adding to 774 existing holdings. Its largest new stake was iShare MSCI Eurozone ETF: 75,058 shares worth $2.82M.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $15.1M trimmed.
- Cambridge Investment Research Advisors's largest Q2 2015 buy was iShare MSCI Eurozone ETF: 75,058 shares worth $2.82M.
- Cambridge Investment Research Advisors added most to iShares MSCI EAFE ETF in Q2 2015, an estimated $16.7M increase.
- Cambridge Investment Research Advisors's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $15.1M.
- Cambridge Investment Research Advisors fully exited Monster Beverage in Q2 2015, selling an estimated $3.19M.
- Cambridge Investment Research Advisors's ten largest holdings make up 19% of its $3.62B portfolio in Q2 2015.
- Cambridge Investment Research Advisors opened 107 new positions and closed 73 in Q2 2015.
- Cambridge Investment Research Advisors's portfolio value rose 3% quarter-over-quarter to $3.62B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2015, filed 29 Jul 2015.